Quality of Service: Katya, a 13 month girl with kidney Wilms’ tumor

Quality of Service: Katya, a 13 month girl with kidney Wilm’s tumorKatya is a 13 months Russian girl. During a routine Ultrasound analysys an abdominal mass was detected, She was diagnosed with Wilms’ kidney tumor and an immediate surgical intervention was recommended. Her parents contacted iMER and she was brought to the Hadassah Medical Center. The affected kidney was removed and the little girl underwent chemotherapy as well, beginning in February 2008.

Since then, Katya has recovered as only a new born child can. Lately she was back for re-check and all tests show she is progressing as a normal child.

Her family wrote:

Katya was born on June 5, 2007. She was a lusty child. Katya was growing and developing normally. We were visiting a pediatrician on a monthly basis and had all standard analyses done. Till the age of 8 months, the girl’s development chart showed no deviation from normal development.

By the age of 8 months Katya became underweight; test data showed some protein in the urine. An urgent examination was necessary.

In February, an ultrasound was made to Katya to reveal a shocking result: the girl’s left kidney had an even-outline 7×7 cm neoplasm, presumably of a benign nature.

On February 8, while browsing the Internet with keywords: “Treatment in Israel”, I found the name of iMER. I addressed the Company and received an answer the same day. I was told that treatment was possible; all I had to do was to provide the Company with my girl’s test data. By that day there still was a hope that is was a benign neoplasm so a surgical intervention was believed to be the way to save the kidney. We chose Israel as the place where the surgery was to be done as that country’s medicine is known to be more loyal to the patient.

On February 9 we visited a nephrology expert who concluded that was not a cyst or a liquid but rather a dense tumor so now surgery was unavoidable. The diagnosis read: “Wilms’ tumor”.

iMER set the appointments for treatment very fast. We forwarded our documents to Moscow via a travel company so by the evening of February 12 we had our Israel visas and air tickets on hands. We flew to Tel Aviv on February 13.

Katya underwent a computer tomography on February 14, and the diagnosis was confirmed.

On February 21 (less than a fortnight following the finding of the tumor) Katya was operated to remove the nephroblastoma together with the kidney. Luckily, the tumor had no metastases at all. We were recommended a set of chemotherapy.

On March 3, an initial set of the chemotherapy began at the Hadassah University Medical Center of Jerusalem. All in all, 7 sets of total length of 11 months were administered to us.

July 7. 2008: the last set. If everything was running smoothly we would undergo a surgery to remove the drainage, have an ultrasound made and then be let go home.

All that time since our first day in Israel we were accompanied by Ms. Lyuba Popovsky, our personal coordinator of iMER. She helped us as an interpreter; she escorted us during our medical consultations, test and surgery at Hadassah; it was she who gave us her helping hand coming to us at any time of day and night, seven days a week; she even was amusing Katya to keep the baby from crying during examinations. Besides, we were given help in our accommodation at Israel: an inexpensive hotel was found for us in Jerusalem; some necessary items like small bath, baby’s cradle, blender etc, were made available to us. We were also given a local mobile phone; some tips about nearest shops were given. We were instructed on key issued relating our stay in Israel and particularly, Jerusalem.

Our family wishes to express our deep gratitude to iMER and personally to Ms. Lyuba Popovsky, Ms. Helen Green, Coordinating Manager, and Dr. Anna Benstein.

Katya’s mother, grandmother, and Katya.

July 8, 2008.

For more information Accutane

Patients’ Stories

This letter was received from a Turkish family who had a child  stricken with a rare skin problem. Local doctors were unable to make a diagnosis nor recommend appropriate treatment. The parents contacted iMER case manager Michael Von Springer seeking help for their child. An initial assessment of the case was made by the iMER medical director Professor Ray Melmed who referred the patient to the Director of the Hadassah Dermatology department Professor Avraham Zlotogorski. Professor Zlotogorsky examined the child and identified the problem.  Successful